A case of fever, sepsis, and chest lesions evident on a computed tomography scan of an indigenous man in northern Australia following burns to the feet is described. Sputum PCR testing revealed Mycobacterium leprae, and a fine-needle aspirate of the chest lesions demonstrated Cryptococcus coinfection.
A 47-year-old indigenous man from East Arnhem, northern Australia, was referred with painful burns to the right foot, having recently stepped on a burning log from a campfire. He reported a cough productive of white sputum for 1 week and weight loss for several months. Medical history included chronic bilateral peripheral neuropathy, iron deficiency anemia, and chronic hepatitis B virus infection. He had a history of heavy alcohol and kava use but denied recent intake. There was no known history of contact with leprosy.
On examination he was febrile (40.8°C), tachycardic (heart rate, 130 beats/min), and hypotensive (blood pressure 85/45 mm Hg). His oxygen saturation was 100% on room air with a respiratory rate of 22. Respiratory examination revealed decreased breath sounds and crepitations bilaterally. He had full-thickness burns to the plantar aspect of the right great, second, and third toes and reduced sensation of the whole right foot in a stocking distribution. Laboratory investigations revealed a hemoglobin level of 93 g/liter (reference range [RR] ,135 to 185) and a white blood cell count of 3.6 ϫ 10 9 /liter (RR, 4.0 to 11.0), with 2.9 ϫ 10 9 neutrophils/liter (RR, 2.0 to 7.5) and 0.6 ϫ 10 9 lymphocytes/liter (RR, 1.5 to 4.0). He had a platelet count of 139 ϫ 10 9 /liter (RR, 150 to 450) and a normal blood glucose level. Chest X-ray demonstrated opacification of the apical segment of the right lower lobe.
He was started on meropenem and azithromycin and placed in respiratory isolation. A computed tomography (CT) scan of the chest revealed two lesions of soft-tissue density within the right lower lobe (maximum diameters, 48 mm and 19 mm) but no lymphadenopathy ( Fig. 1) . A serum cryptococcal antigen test was positive (titer, 1:64; Remel, Lenexa, KS). Microscopy of a fineneedle aspiration biopsy specimen from one of the chest lesions showed numerous fungal organisms consistent with Cryptococcus species.
One of three sputum specimens demonstrated scanty acid-fast bacilli (AFB) by Ziehl-Neelsen staining. PCR for Mycobacterium tuberculosis complex was negative on this sample. A subsequent generic PCR for mycobacteria yielded a 220-bp product; restriction digestion of the amplified product using HaeIII and CfoI gave a differential identification of Mycobacterium kansasii, Mycobacterium celatum, orMycobacterium leprae (1). Sequencing of the amplified product resulted in a 100% match with the internal transcribed spacer (ITS) region of M. leprae.
On further clinical review, leonine facies and thinning eyebrows were noted (Fig. 2) , but there was no evidence of dermatological hypopigmentation. The left greater auricular, right median, bilateral ulnar, and bilateral popliteal nerves were enlarged, and there was sensory loss on pinprick testing of the right foot (2 on a scale of 10) compared to the left. Slit-skin examination of the eyebrows, earlobes, and nose showed AFB with a bacillary index of 4 consistent with multibacillary leprosy.
The patient was initially started on standard treatment for tuberculosis following the finding of sputum AFB positivity. When PCR and sequencing results became available, the tuberculosis treatment was stopped and rifampin, clofazimine, and ofloxacin were commenced in accordance with the Guidelines for Leprosy Control in the Northern Territory (2). The cryptococcal infection was treated with 6 weeks of intravenous amphotericin and flucytosine and then oral fluconazole. Ofloxacin was substituted for dapsone to prevent the potential interaction between fluconazole and dapsone. The patient was treated for both conditions for a total of 24 months and made a full recovery.
The diagnosis of leprosy is usually made based on clinical features in patients with known risk exposure and confirmed by slitskin examination or nerve biopsy. PCR on DNA extracted from various tissues (mainly skin) has been applied as an additional confirmatory test (3). Our patient was unusual in that the primary diagnosis was made following a positive Ziehl-Neelsen stain result using a generic mycobacterial PCR and confirmed on clinical review and slit-skin examination. The Ziehl-Neelsen stain is not sensitive for M. leprae but was positive in this case, which enabled the performance of further rapid testing for mycobacteria. To our knowledge, the use of PCR on sputum samples to differentiate between tuberculosis and leprosy has been previously reported only in Nepal (4). The most specific PCR to detect M. leprae targets the repetitive element (RLEP) gene (5, 6) . This PCR was not available at the time of presentation but has subsequently been performed on the patient's sputum with a positive result.
The most prevalent mycobacterial disease within Australia is tuberculosis, which occurs in the indigenous population at rates up to 7 times those of nonindigenous Australians (7). Leprosy, caused by Mycobacterium leprae, was endemic in the indigenous population in northern Australia until the 1960s but over the last 10 years has been diagnosed infrequently across Australia, with 5 to 13 cases per year. A high proportion of infections continue to occur in the indigenous population (8) . Cryptococcosis is also more common in the indigenous population of northern Australia (9) . While leprosy and tuberculosis are often endemic in similar geographic regions, we are aware of only three reports of concurrent leprosy and cryptococcal infection (10, 11) .
Due to its rarity within Australia, the diagnosis of leprosy is often delayed, the median interval between onset of symptoms and diagnosis being 2 years (12) . This case highlights the need for ongoing awareness of leprosy in low-prevalence countries, particularly in at-risk populations such as the indigenous population in northern Australia or in people born in higher-prevalence countries. It also provides evidence that leprosy can be diagnosed from sputum and that PCR can be effectively utilized to distinguish between different mycobacterial species in sputum samples positive for AFB. This was especially important in this case, where the organism was one that is unable to be routinely cultured and that without the PCR/sequencing result, the leprosy diagnosis may have been missed or delayed.
